logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Molecular Formula C17H20F2N4O3S Omarigliptin CAS 1226781-44-7

Molecular Formula C17H20F2N4O3S Omarigliptin CAS 1226781-44-7

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1226781-44-7

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

CAS 1226781-44-7 Omarigliptin

,

Molecular Formula C17H20F2N4O3S Omarigliptin

CAS NO::
1226781-44-7
Appearance ::
White Powder
Molecular Formula::
C17H20F2N4O3S
Molecular Weight::
398.428
EINECS NO::
682-558-0
MDL NO::
MFCD22573261
CAS NO::
1226781-44-7
Appearance ::
White Powder
Molecular Formula::
C17H20F2N4O3S
Molecular Weight::
398.428
EINECS NO::
682-558-0
MDL NO::
MFCD22573261
Molecular Formula C17H20F2N4O3S Omarigliptin CAS 1226781-44-7

Product Description:

Product Name: Omarigliptin CAS NO:1226781-44-7

 

 

 

 

 

 

Synonyms:

MK-3102;

(2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]-tetrahydro-2H-pyran-3-amine;

 

 

 

 

 

 

 

Chemical & Physical Properties:

Appearance : White powder

Assay :≥99.0%

Density:1.6 g/cm3

Boiling Point:529.4℃ at 760 mmHg

Flash Point:274.0±32.9 ℃

 

 

 

 

 

 

 

 

Augagliptin (MK-3102) is an ultra-long-acting dipeptidyl peptidase-4 (DPP-4) inhibitor, an oral hypoglycemic agent developed by Merck & Co., once a week. It can produce continuous DPP. -4 Inhibition, has a brand-new blood sugar lowering mechanism, and has the advantages of not increasing weight, not causing hypoglycemia, and not causing edema. The mechanism of action is by inhibiting the degradation of glucagon-like peptide-1 (GLP-1) by DPP-4 enzyme in the body, prolonging the action time of GLP-1, thereby increasing the endogenous GLP-1 and GIP in the blood Concentration, and ultimately improve blood sugar control.

 

 

 

 

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

 

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.